235 related articles for article (PubMed ID: 22487579)
1. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
Liu X; Li Y; Zhang Y; Du W; Sun S; Lin B; Chen H; Cheng L
Retina; 2012 Oct; 32(9):1838-43. PubMed ID: 22487579
[TBL] [Abstract][Full Text] [Related]
2. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Kawamura R; Inoue M; Shinoda H; Shinoda K; Itoh Y; Ishida S; Tsubota K
J Ocul Pharmacol Ther; 2011 Jun; 27(3):299-304. PubMed ID: 21510808
[TBL] [Abstract][Full Text] [Related]
3. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Yang YH; Hsu WC; Hsieh YT
Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
[TBL] [Abstract][Full Text] [Related]
4. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
Chan LW; Hsu WC; Hsieh YT
J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide and intraocular pressure.
Smithen LM; Ober MD; Maranan L; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
[TBL] [Abstract][Full Text] [Related]
9. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
Bakri SJ; Beer PM
Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
[TBL] [Abstract][Full Text] [Related]
10. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
11. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
13. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and risk factors of intraocular pressure elevation after triamcinolone acetonide administration for macular disorders].
Ito T; Nozaki M; Ogura Y
Nippon Ganka Gakkai Zasshi; 2006 May; 110(5):379-83. PubMed ID: 16764319
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
Jea SY; Byon IS; Oum BS
Korean J Ophthalmol; 2006 Jun; 20(2):99-103. PubMed ID: 16892645
[TBL] [Abstract][Full Text] [Related]
17. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
19. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Chew EY; Glassman AR; Beck RW; Bressler NM; Fish GE; Ferris FL; Kinyoun JL;
Retina; 2011 Feb; 31(2):284-9. PubMed ID: 20948459
[TBL] [Abstract][Full Text] [Related]
20. Association of OCT angle recess width with IOP response after intravitreal triamcinolone injection.
Singer MA; Groth SL; Sponsel WE; Herro A; Pollard J; Cohen SR; Cohen JH
Retina; 2013 Feb; 33(2):282-6. PubMed ID: 22846803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
